-
Je něco špatně v tomto záznamu ?
p19-Targeting ILP Protein Blockers of IL-23/Th-17 Pro-Inflammatory Axis Displayed on Engineered Bacteria of Food Origin
K. Škrlec, P. Zadravec, M. Hlavničková, M. Kuchař, L. Vaňková, H. Petroková, L. Křížová, J. Černý, A. Berlec, P. Malý,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
NV16-27676A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
29966384
DOI
10.3390/ijms19071933
Knihovny.cz E-zdroje
- MeSH
- buňky Th17 účinky léků MeSH
- ELISA MeSH
- interleukin-23 metabolismus MeSH
- Lactococcus lactis metabolismus MeSH
- lidé MeSH
- proteiny genetika metabolismus farmakologie MeSH
- průtoková cytometrie MeSH
- rekombinantní proteiny genetika metabolismus farmakologie MeSH
- vazba proteinů MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
IL-23-mediated Th-17 cell activation and stimulation of IL-17-driven pro-inflammatory axis has been associated with autoimmunity disorders such as Inflammatory Bowel Disease (IBD) or Crohn’s Disease (CD). Recently we developed a unique class of IL-23-specific protein blockers, called ILP binding proteins that inhibit binding of IL-23 to its cognate cell-surface receptor (IL-23R) and exhibit immunosuppressive effect on human primary blood leukocytes ex vivo. In this study, we aimed to generate a recombinant Lactococcus lactis strain which could serve as in vivo producer/secretor of IL-23 protein blockers into the gut. To achieve this goal, we introduced ILP030, ILP317 and ILP323 cDNA sequences into expression plasmid vector containing USP45 secretion signal, FLAG sequence consensus and LysM-containing cA surface anchor (AcmA) ensuring cell-surface peptidoglycan anchoring. We demonstrate that all ILP variants are expressed in L. lactis cells, efficiently transported and secreted from the cell and displayed on the bacterial surface. The binding function of AcmA-immobilized ILP proteins is documented by interaction with a recombinant p19 protein, alpha subunit of human IL-23, which was assembled in the form of a fusion with Thioredoxin A. ILP317 variant exhibits the best binding to the human IL-23 cytokine, as demonstrated for particular L.lactis-ILP recombinant variants by Enzyme-Linked ImmunoSorbent Assay (ELISA). We conclude that novel recombinant ILP-secreting L. lactis strains were developed that might be useful for further in vivo studies of IL-23-mediated inflammation on animal model of experimentally-induced colitis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000596
- 003
- CZ-PrNML
- 005
- 20190107104409.0
- 007
- ta
- 008
- 190107s2018 sz f 000 0|eng||
- 024 7_
- $a 10.3390/ijms19071933 $2 doi
- 035 __
- $a (PubMed)29966384
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Škrlec, Katja $u Department of Biotechnology, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia. katja.skrlec@ijs.si. Graduate School of Biomedicine, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia. katja.skrlec@ijs.si.
- 245 10
- $a p19-Targeting ILP Protein Blockers of IL-23/Th-17 Pro-Inflammatory Axis Displayed on Engineered Bacteria of Food Origin / $c K. Škrlec, P. Zadravec, M. Hlavničková, M. Kuchař, L. Vaňková, H. Petroková, L. Křížová, J. Černý, A. Berlec, P. Malý,
- 520 9_
- $a IL-23-mediated Th-17 cell activation and stimulation of IL-17-driven pro-inflammatory axis has been associated with autoimmunity disorders such as Inflammatory Bowel Disease (IBD) or Crohn’s Disease (CD). Recently we developed a unique class of IL-23-specific protein blockers, called ILP binding proteins that inhibit binding of IL-23 to its cognate cell-surface receptor (IL-23R) and exhibit immunosuppressive effect on human primary blood leukocytes ex vivo. In this study, we aimed to generate a recombinant Lactococcus lactis strain which could serve as in vivo producer/secretor of IL-23 protein blockers into the gut. To achieve this goal, we introduced ILP030, ILP317 and ILP323 cDNA sequences into expression plasmid vector containing USP45 secretion signal, FLAG sequence consensus and LysM-containing cA surface anchor (AcmA) ensuring cell-surface peptidoglycan anchoring. We demonstrate that all ILP variants are expressed in L. lactis cells, efficiently transported and secreted from the cell and displayed on the bacterial surface. The binding function of AcmA-immobilized ILP proteins is documented by interaction with a recombinant p19 protein, alpha subunit of human IL-23, which was assembled in the form of a fusion with Thioredoxin A. ILP317 variant exhibits the best binding to the human IL-23 cytokine, as demonstrated for particular L.lactis-ILP recombinant variants by Enzyme-Linked ImmunoSorbent Assay (ELISA). We conclude that novel recombinant ILP-secreting L. lactis strains were developed that might be useful for further in vivo studies of IL-23-mediated inflammation on animal model of experimentally-induced colitis.
- 650 _2
- $a ELISA $7 D004797
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interleukin-23 $x metabolismus $7 D053759
- 650 _2
- $a Lactococcus lactis $x metabolismus $7 D013294
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a proteiny $x genetika $x metabolismus $x farmakologie $7 D011506
- 650 _2
- $a rekombinantní proteiny $x genetika $x metabolismus $x farmakologie $7 D011994
- 650 _2
- $a buňky Th17 $x účinky léků $7 D058504
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zadravec, Petra $u Department of Biotechnology, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia. petrazadravec@gmail.com.
- 700 1_
- $a Hlavničková, Marie $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, v. v. i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. marie.hlavnickova@ibt.cas.cz.
- 700 1_
- $a Kuchař, Milan $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, v. v. i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. milan.kuchar@ibt.cas.cz.
- 700 1_
- $a Vaňková, Lucie $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, v. v. i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. lucie.vankova@ibt.cas.cz.
- 700 1_
- $a Petroková, Hana $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, v. v. i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. hana.petrokova@ibt.cas.cz.
- 700 1_
- $a Křížová, Lucie $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, v. v. i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. lucie.krizova@ibt.cas.cz.
- 700 1_
- $a Černý, Jiří $u Laboratory of Structural Bioinformatics of Proteins, Institute of Biotechnology of the Czech Academy of Sciences, v. v. i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. jiri.cerny@ibt.cas.cz.
- 700 1_
- $a Berlec, Aleš $u Department of Biotechnology, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia. ales.berlec@ijs.si. Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. ales.berlec@ijs.si.
- 700 1_
- $a Malý, Petr $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, v. v. i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. petr.maly@ibt.cas.cz.
- 773 0_
- $w MED00176142 $t Int J Mol Sci $x 1422-0067 $g Roč. 19, č. 7 (2018), s.
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29966384 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a
- 990 __
- $a 20190107 $b ABA008
- 999 __
- $a ok $b bmc $g 1364648 $s 1038719
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 19 $c 7 $e 20180701 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a NV16-27676A $p MZ0
- LZP __
- $a Pubmed-20190107